ADAC Cited By FDA For Design Control, Recall Reporting Violations
This article was originally published in The Gray Sheet
Executive Summary
Philips Medical/ADAC Laboratories failed to properly validate and verify changes to the Forte gamma camera system, FDA states in an Oct. 25 warning letter following an inspection of the firm's Milpitas, California facility in September